• Label License Statement

NOTICE TO PURCHASER:  LIMITED LICENSE

Use of this product is covered by one or more of the following US patents and corresponding patent claims outside the US:  5,079,352, 5,789,224, 5,618,711, 6,127,155, 5,677,152, and 5,773,258, 5,407,800, 5,322,770, 5,310,652, 5,066,584, and claims outside the US corresponding to US Patent No. 4,889,818. The purchase of this product includes a limited, non-transferable immunity from suit under the foregoing patent claims for using only this amount of product solely in [Licensed Application Field], including reporting results of purchaser’s activities for a fee or other commercial consideration, and also for the purchaser's own internal research. No right under any other patent claim (such as the patented 5’ nuclease process claims in US Patents Nos. 5,210,015 and 5,487,972) is conveyed expressly, by implication, or by estoppel. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.


Short Statement

Purchase of this product includes an immunity from suit under patents specified in the product insert to use only the amount purchased solely in [Licensed Application Field] and also for the purchaser’s own internal research.  No other patent rights (such as 5’ nuclease process patent rights) are conveyed expressly, by implication, or by estoppel. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.  

This Label License Statement should not be used if another statement herein applies that conveys Chemically-Modified Hot-Start Polymerase Patent Rights and Chemically-Modified Hot-Start Polymerase Kit Patent Rights.